Leidos, Amazon.com, Halozyme Therapeutics and BioMarin Pharmaceutical are part of the Zacks Screen of the Week article.

Shares of Leidos Holdings Inc. LDOS inched 0.74% higher to $148.24 Monday, on what proved to be an all-around mixed trading ...

Leidos (NYSE:LDOS) today announced that its wholly owned subsidiary, QTC Medical Services, operating under the brand name ...

Leidos Holdings Inc. closed $59.60 below its 52-week high ($202.90), which the company achieved on November 12th.

The company can trace its incumbency on this program to 2013 and now manufactures some of the airport security equipment ...

Jefferies analyst Sheila Kahyaoglu lowered the firm’s price target on Leidos (LDOS) to $160 from $175 and keeps a Hold rating on the shares.

Learn about how Leidos will provide General Electronic Test Station, or GETS, equipment, hardware, software, upgrades and ...

Learn more about VA's selection of four vendors for a recompete IDIQ contract to provide medical disability examination services in Regions 1 through 4.

Roger Krone, former Chairman and CEO of Leidos, departs Board to focus on Boy Scouts of AmericaJean Bua, CFO of NetScout Systems, appointed to ...

Four incumbents keep their spots on the vehicle that exceeded its $6.8 billion ceiling as PACT Act claims drives a surge in ...

Rocket Lab USA, Inc. (NASDAQ: RKLB) shares are trading higher Monday following the announcement that the company will play a ...